TEVA PHARMACEUTICAL INDUSTRIES LTD
Pharmaceutical Preparations · TEL AVIV
High confidence (85%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.
Latest material event: TEVA PHARMACEUTICAL INDUSTRIES LTD was delisted from its exchange (Sep 14, 2026)
Timeline
Every material event, newest first. History is never overwritten.
TEVA PHARMACEUTICAL INDUSTRIES LTD was delisted from its exchange
Sep 14, 2026
Delisting effective
- SEC EDGAR — “X0203 0000876661 NEW YORK STOCK EXCHANGE LLC 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD 001-16174 124 Dvora Hanevia St Tel Aviv 4951033 972 (3) 914-8213 American Depositary Shares, each representing one Ordinary Share 17 CFR 240.12d2-2(a)(3) Victoria Paper Manager, Market Watch 2026-09-14”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the tickers TEVA and TEVJF on NYSE and OTC.
- SEC CIK
- 0000818686
- Website
- —
- —
- Headquarters
- TEL AVIV
- Also known as
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Legal entities
- TEVA PHARMACEUTICAL INDUSTRIES LTD
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
TEVA PHARMACEUTICAL INDUSTRIES LTD — Pharmaceutical Preparations (SIC 2834) — TEL AVIV
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0000876661 NEW YORK STOCK EXCHANGE LLC 0000818686 TEVA PHARMACEUTICAL INDUSTRIES LTD 001-16174 124 Dvora Hanevia St Tel Aviv 4951033 972 (3) 914-8213 American Depositary Shares, each representing one Ordinary Share 17 CFR 240.12d2-2(a)(3) Victoria Paper Manager, Market Watch 2026-09-14
View source record
Status history
Every derived status, with the rule that produced it.
- UNKNOWN → NO_LONGER_LISTEDPUBLIC_LISTING_ENDED · Sep 20, 2026, 12:14 AM
The company stopped being publicly listed. A listing ends on the close of a merger as surely as it ends in failure, and the filing does not say which happened here.